Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Xiamen Amoytop Biotech CoSHSE:688278 -5.32%75 3-Year ROIIC % is 41.59 as of Dec. 2025, which is 27% below its 10-year median of 56.79. GuruFocus rates SHSE:688278 with a GF Score™ of 75/100 and a GF Value™ of ¥105.34 (Possible Value Trap). The stock has 2 warning signs investors should review. Among 1,316 Biotechnology companies, Xiamen Amoytop Biotech Co ranks better than 70.67% on this metric.
3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year.
Xiamen Amoytop Biotech Co's 3-Year ROIIC % for the quarter that ended in Dec. 2025 was 41.59%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for Xiamen Amoytop Biotech Co's 3-Year ROIIC % or its related term are showing as below:
SHSE:688278's 3-Year ROIIC % is ranked better than 70.67% of 1316
companies
in the Biotechnology industry
Industry Median: -4.63
vs SHSE:688278: 41.59
Xiamen Amoytop Biotech Co (SHSE:688278) 3-Year ROIIC % Explanation
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Xiamen Amoytop Biotech Co 3-Year ROIIC % Related Terms
Xiamen Amoytop Biotech Co 3-Year ROIIC % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SHSE:688278 vs VRTX, REGN, RVMD: 3-Year ROIIC % Comparison
For the Biotechnology subindustry, Xiamen Amoytop Biotech Co's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Xiamen Amoytop Biotech Co 3-Year ROIIC % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Xiamen Amoytop Biotech Co's 3-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Xiamen Amoytop Biotech Co's 3-Year ROIIC % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Xiamen Amoytop Biotech Co (SHSE:688278) has a 3-Year ROIIC % of 41.59 as of Dec. 2025. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Xiamen Amoytop Biotech Co and its competitors. This is 27% below median its historical median of 56.79. Over the past decade, Xiamen Amoytop Biotech Co's 3-Year ROIIC % has ranged from 41.59 to 155.63. According to the industry distribution chart, Xiamen Amoytop Biotech Co ranks #386 out of 1316 companies in the Biotechnology industry, placing it in the top 29.3%.
Is Xiamen Amoytop Biotech Co's 3-Year ROIIC % too high?
Xiamen Amoytop Biotech Co's current 3-Year ROIIC % of 41.59 is 27% below median its 10-year median of 56.79. Over the past 10 years, this metric has ranged from a low of 41.59 to a high of 155.63. Based on the distribution chart, Xiamen Amoytop Biotech Co ranks #386 out of 1316 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Xiamen Amoytop Biotech Co has a GF Score™ of 75/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Xiamen Amoytop Biotech Co's 3-Year ROIIC % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Xiamen Amoytop Biotech Co ranks #386 out of 1316 companies for 3-Year ROIIC %. This puts Xiamen Amoytop Biotech Co in the upper half of its industry. Historically, Xiamen Amoytop Biotech Co's own 3-Year ROIIC % has ranged from 41.59 to 155.63 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for a Biotechnology company?
A good 3-Year ROIIC % depends on the Biotechnology industry context. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Xiamen Amoytop Biotech Co and its competitors. Xiamen Amoytop Biotech Co's current 3-Year ROIIC % is 41.59, which is 27% below median its own 10-year median of 56.79. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Xiamen Amoytop Biotech Co stock overvalued right now?
Based on GuruFocus' analysis, Xiamen Amoytop Biotech Co (SHSE:688278) is currently considered Possible Value Trap. The stock's GF Value™ is ¥105.34, compared to a current price of ¥61.53 — trading 41.6% below its estimated fair value. The current 3-Year ROIIC % is 41.59, which is 27% below median its 10-year median of 56.79. Xiamen Amoytop Biotech Co's overall GF Score™ is 75/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For Xiamen Amoytop Biotech Co (SHSE:688278), the current 3-Year ROIIC % is 41.59 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Xiamen Amoytop Biotech Co (SHSE:688278) Overvalued in 2026?
Based on GuruFocus' analysis, Xiamen Amoytop Biotech Co stock appears to be undervalued.
The current stock price of ¥61.53 is trading 41.6% below its estimated GF Value™ of ¥105.34.
GuruFocus considers Xiamen Amoytop Biotech Co to be Possible Value Trap.
Key valuation signals for SHSE:688278:
3-Year ROIIC %: 41.59 (27% below median its 10-year median of 56.79)
GF Value™: ¥105.34 vs. price of ¥61.53 (41.6% below fair value)
No single metric tells the full story. See the SHSE:688278 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Xiamen Amoytop Biotech Co Ltd operates as a drug development company. The Company develops and sells protein drugs, interferon drugs, and other products.
75GF Score
Get the complete analysis for SHSE:688278
3-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688278 has been successfully added to your 
